21.40
0.26 (1.23%)
0.26 (1.23%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aclaris Therapeutics Inc | ACRS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.26 | 1.23% | 21.40 | 19:34:42 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 21.36 | 19.8501 | 21.90 | 21.31 | 21.14 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 21.40 | 21.50 | 0.10 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,734 | 605,975 | $ 20.85 | $ 12,634,156 | 5,520,502 | 0.70 - 25.48 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:34:42 | formt | 100 | $ 21.40 | USD |
Aclaris Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 963.65M | 45.03M | 42.99M | $ 12.98M | $ - | -3.90 | -13.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Aclaris Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ACRS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 21.21 | 24.33 | 19.8501 | 22.40 | 421,644 | 0.19 | 0.9% |
| 1 Month | 21.50 | 25.48 | 19.51 | 22.13 | 849,190 | -0.10 | -0.47% |
| 3 Months | 3.73 | 25.48 | 3.60 | 17.32 | 3,307,208 | 17.67 | 473.73% |
| 6 Months | 2.10 | 25.48 | 1.99 | 15.56 | 1,733,629 | 19.30 | 919.05% |
| 1 Year | 1.20 | 25.48 | 0.70 | 12.21 | 1,122,714 | 20.20 | 1,683.33% |
| 3 Years | 20.33 | 25.48 | 0.70 | 8.27 | 827,313 | 1.07 | 5.26% |
| 5 Years | 19.60 | 33.25 | 0.70 | 10.77 | 585,557 | 1.80 | 9.18% |
Aclaris Therapeutics Description
| Aclaris Therapeutics Inc is a clinical-stage specialty pharmaceutical company which operates in United States. It focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology. The company holds a drug candidate, A-101 Topical Solution which is a proprietary high-concentration hydrogen peroxide topical solution which is being developed as a prescription treatment for seborrheic keratosis (SK) a common non-malignant skin tumor. Its pipeline of drug candidates includes A-101 as a Topical Solution for treatment of SK, common warts; A-102 as a gel dosage form for treatment of SK and warts and A-201 and A-301 as an oral and topical formulation for treatment of autoimmune dermatologic respectively. |
